Moleculin Biotech Files 8-K
Ticker: MBRX · Form: 8-K · Filed: May 7, 2025 · CIK: 1659617
Sentiment: neutral
Topics: 8-K, disclosure, financials
Related Tickers: MBRX
TL;DR
Moleculin Biotech (MBRX) filed an 8-K on May 7th for Reg FD and financial exhibits.
AI Summary
Moleculin Biotech, Inc. filed an 8-K on May 7, 2025, reporting on events that occurred on the same date. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits. The company is incorporated in Delaware and headquartered in Houston, Texas.
Why It Matters
This 8-K filing provides important updates and disclosures for investors regarding Moleculin Biotech, Inc.'s regulatory and financial reporting.
Risk Assessment
Risk Level: low — This filing is a routine disclosure and does not appear to contain significant new risks or material adverse information.
Key Players & Entities
- Moleculin Biotech, Inc. (company) — Registrant
- May 7, 2025 (date) — Date of Report
- Houston, TX (location) — Principal Executive Offices
FAQ
What is the primary purpose of this 8-K filing?
This 8-K filing serves as a Current Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, primarily for Regulation FD Disclosure and Financial Statements and Exhibits.
When was the earliest event reported in this filing?
The earliest event reported in this filing occurred on May 7, 2025.
Where is Moleculin Biotech, Inc. headquartered?
Moleculin Biotech, Inc.'s principal executive offices are located at 5300 Memorial Drive, Suite 950, Houston, TX 77007.
What is the company's state of incorporation?
Moleculin Biotech, Inc. is incorporated in Delaware.
What is the company's IRS Employer Identification Number?
The company's IRS Employer Identification Number is 47-4671997.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 7, 2025 regarding Moleculin Biotech, Inc. (MBRX).